Cel-Sci
CVM
$1.72
Share price
5.52%
Change (1 day)
-31.20%
Change (1 year)
Categories
Cel-Sci (CVM) - Total assets
Total assets on the balance sheet as of December 2023 : $28.71 M
According to Cel-Sci 's latest financial reports the company's total assets are $28.71 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cel-Sci - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-09-30 | $30.52 M | -39.58% |
| 2022-09-30 | $50.52 M | -33.41% |
| 2021-09-30 | $75.86 M | 87.16% |
| 2020-09-30 | $40.53 M | 46.75% |
| 2019-09-30 | $27.62 M | -6.64% |
| 2018-09-30 | $29.58 M | 29.06% |
| 2017-09-30 | $22.92 M | -7.88% |
| 2016-09-30 | $24.88 M | -12.84% |
| 2015-09-30 | $28.55 M | 48.48% |
| 2014-09-30 | $19.23 M | 77.43% |
| 2013-09-30 | $10.83 M | -32.54% |
| 2012-09-30 | $16.06 M | -13.73% |
| 2011-09-30 | $18.62 M | -50.73% |
| 2010-09-30 | $37.8 M | -17.86% |
| 2009-09-30 | $46.02 M | 213.46% |
| 2008-09-30 | $14.68 M | -29.17% |
| 2007-09-30 | $20.73 M | 114.75% |
| 2006-09-30 | $9.65 M | 212.17% |
| 2005-09-30 | $3.09 M | -43.92% |
| 2004-09-30 | $5.51 M | 89.14% |
| 2003-09-30 | $2.91 M | -22.7% |
| 2002-09-30 | $3.77 M | -16.36% |
| 2001-09-30 | $4.5 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 598,871.79% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 338,295.41% | 🇺🇸 USA |
 Xencor XNCR | $0.95 B | 3,218.30% | 🇺🇸 USA |
 Curis CRIS | $77.28 M | 169.18% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 151,340.95% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | $0.51 B | 1,700.61% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 6,250.36% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $49.13 M | 71.13% | 🇺🇸 USA |